46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

✍ Scribed by S. Hadziyannis; N. Tassopoulos; T.T. Chang; J. Heathcote; G. Kitis; M. Rizzetto; P. Marcellin; S.G. Lim; S.S. Chen; S. Arterburn; J. Ma; S. Xiong; M. Wollman; C. James; G. Currie; C.L. Brosgart

• Book ID: 117372876
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 60 KB
• Volume: 40
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(04)90046-3